Procedures for Developing the NIOSH List of Hazardous Drugs … For the fourth year in a row, “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016” was the most downloaded document from the NIOSH website. List of Hazardous Drugs NIOSH maintains a list of antineoplastic and other HDs used in healthcare. The NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings builds on a NIOSH alert from 2004 that warned healthcare employers and workers of the risks of working with hazardous drugs and discussed measures they could take to protect their health. Please include the URL of the site in the Subject line of your email request that you would like to access. On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH) released the long-awaited proposed “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020”, as well as “Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings” and “Managing Hazardous Drug Exposures: Information for Healthcare Settings” in the Federal Register. In the 2020 NIOSH List of Hazardous Drugs in Healthcare Settings that NIOSH has published for public comment, antineoplastic HDs have been included in Table 1 and 2, whereas in previous NIOSH lists, antineoplastic HDs were only included in Table 1. NIOSH Updates List of Hazardous Drugs in Healthcare Settings for 2020 May 7, 2020 Trainers Gain New Features in Update to NIOSH Software That Helps Miners Recognize Hazards NIOSH has published for comment the long-awaited revised 2020 Hazardous Drug List along with information for managing hazardous drug exposure and the NIOSH procedures for developing the list. The proposal includes a name change and reorganization of drug lists so that not all antineoplastic drugs, most often associated with cancer treatments, are grouped together. The list was updated in 2010 and will be updated periodically as new drugs become available. NIOSH Docket Office Robert A. Taft Laboratories 1090 Tusculum Avenue MS-C-34 Cincinnati, OH 45226-1998 . Five drugs have been removed. All are open for a 60 day comment period. Accessed July 16, 2020. Reg. CDC twenty four seven. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 B. The 2020 version of NIOSH’s list groups drugs by hazard. Formerly the “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings,” the list will be called more simply the “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020.” If emailing please type “508 Accommodation PR#9342” without quotes in the subject line of the email. ISMP's List of Confused Drug Names contains look-alike and sound-alike (LASA) name pairs, of medications that have been published in the ISMP Medication Safety Alert! The CMP EC revised <800> to clarify that for the The agency has also retitled and reorganized the document. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. The document also describes the process for requesting drugs’ removal from or placement on the list. Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Interested parties are invited to participate in this action by submitting written views, opinions, recommendation, and/or data. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click “Search.”, Comments will be accepted until 11:59 p.m. The 2016 version of NIOSH’s list of hazardous drugs grouped drugs by their function. ® Community/Ambulatory Care Edition through February 28, 2019.. Use this list to determine which medications require special safeguards to reduce the risk of errors and minimize harm. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. By Connor TH, MacKenzieBA, DeBordDG, Trout DB, O’Callaghan JP, OvesenJL, Whittaker C. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safe ty and Health, DHHS (NIOSH) Publication Number 2020 -xxx Sixteen drugs have been added to NIOSH’s 2020 list, including three for which the manufacturers have provided special handling information. NIOSH also seeks comment on the draft Policy and Procedures for Developing the NIOSH List of Antineoplastic and Other Hazardous … Cepastat lozenge N/ABlack EPA Cerubidine N/ABlack EPA Formerly the “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings,” the list will be called more simply the “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020.” The list, which is a basic reference document for OSHA, USP and other standard-setting organizations, has not been updated since 2016. In 2004, NIOSH published a NIOSH Alert and list of hazardous drugs with active input from partners in the healthcare industry, the pharmaceutical industry, and federal agencies. In the 2020 NIOSH List of Hazardous Drugs in Healthcare Settings that is published for public comment, antineoplastic HDs have been included in Table 1 and 2, whereas in previous NIOSH lists, antineoplastic HDs were only included in Table 1. The Federal Register Notice for the Draft of the 2020 NIOSH List of Hazardous Drugs is now available. Continuing Education Credits & Certification Maintenance, Core Competencies for the Practice of Industrial Occupational Hygiene, Journal of Occupational and Environmental Hygiene (JOEH), NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings. Based on input from the public and stakeholders, including conflicting evidence about the hazards posed by botulinum toxins to workers, NIOSH is not currently proposing that botulinum toxins be added to the list. The second table lists drugs that meet the agency’s definition of a hazardous drug, but do not have special handling instructions and are not classified as carcinogenic by NTP or IARC. NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings pdf icon [PDF – 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 pdf icon [PDF – 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings pdf icon [PDF – 4 MB] ® and the ISMP Medication Safety Alert! CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Abacavir Blue Trash Yellow NIOSH Abiraterone Black Yellow NIOSH Acetaminophen elixir N/ABlack Trash EPA Single pair of gloves: ... Harzardous Drug Medication List Personal Protective Equiptment for Working with Hazardous Drugs. As a result, drugs that required different protective measures were grouped together. 5 of a hazardous drug. RE: Docket CDC-2020-0046, Docket Number NIOSH-233-C for “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information”. The Joint Consensus Statement, endorsed by AIHA and the other organizations, summarizes what occupational health professionals and scientists currently know about airborne SARS-CoV-2 transmission. The goals of these standards are to help increase awareness, provide uniform guidance to reduce the risk of managing hazardous drugs, and help reduce the risk posed to patients and the healthcare workforce. NIOSH has formalized the methodology NIOSH uses to guide the addition of drugs to or removal of drugs from the List, in a document entitled Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures).1 As stated in the Procedures, NIOSH defines a hazardous drug as a drug that is: 1 NIOSH [2020]. Comment: NIOSH indicated that 10 drugs—cetuximab, ibrutinib, ipilmumab, necitumumab, nintedanib, nivolumab, palbociclib, panitumumab, ramucirumab, and ruxolitinib—demonstrated available information that shows a toxic effect that does not meet the NIOSH definition of a hazardous drug. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. According to NIOSH, one table comprises drugs that contain special handling information specified by the manufacturer or meet the NIOSH definition of a hazardous drug and are classified as “known to be a human carcinogen” by the National Toxicology Program or as “carcinogenic” or “probably carcinogenic” by the International Agency for Research on Cancer. The public comment period for the NIOSH List of Hazardous Drugs in Healthcare Settings for 2020, Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and Managing Hazardous Drug Exposures: Information for Healthcare Settings will be open until June 30, 2020. Entity must maintain a list of HDs, which must include any items on the current NIOSH list that the entity handles. The new name for the list, the NIOSH List of Hazardous Drugs in Healthcare Settings, updates the previous title, the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings. Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. In Massachusetts, the state’s Department of Public Health is working with workplace health and safety stakeholders, substance addiction service providers, and policy makers to provide opioid awareness peer training for high risk worker groups and identify other additional opportunities to implement worker-oriented … March 28, 2020 Robert R. Redfield, MD Director Centers for Disease Control and Prevention 1600 Clifton Rd., MS D-14 Atlanta, GA 30333 Dear Dr. Redfield: Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. The agency has updated its List of Hazardous Drugs in Healthcare Settings for 2020 as well as its procedures for developing the list. Drugs are further grouped into two tables. Nearly 668,000 NIOSH documents were downloaded from the website in 2020. NIOSH Antineoplastic and Other Hazardous Drugs As a refresher, The National Institute for Occupational Safety and Health (NIOSH) offers a list of “Antineoplastic and Other Hazardous Drugs in Healthcare Settings.” This publication was last updated in 2016, but more recent changes have been posted to the CDC website. develop your own list based on unique utilization patterns and internal data about medication errors and sentinel events collaborate with your pharmacy consultant to help develop your list review National Institute for Occupational Safety and Health (NIOSH) resources to help develop a unique list of high-alert and hazardous medications Occupational Safety and Health (NIOSH) list. Accordingly, NIOSH is not proposing to place these two drugs on the List. While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2) reevaluate its decision to place a drug on the List … Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. Visit the docket page on Regulations.gov to view the draft documents and instructions on submitting comments. must be reviewed at least every 12 months and whenever a … ET on July 30, 2020. NIOSH Announces that the draft 2020 NIOSH List of Hazardous Drugs in Healthcare Settings is available for public comment which includes the drugs proposed for placement on the 2020 List. In the February 2018 Request for Comment, NIOSH requested comment on a draft Policy and Procedures for developing the List.The draft Policy and Procedures document was developed to formalize the methodology NIOSH uses to guide the addition of hazardous drugs to the List and create a process for requesting the removal from or placement of drugs on the List. NIOSH previously proposed an entire class of drug, botulinum toxins, for placement on the list. Centers for Disease Control and Prevention. You will be subject to the destination website's privacy policy when you follow the link. Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings is intended to formalize the methodology that NIOSH uses to add hazardous drugs to its list. NIOSH-List-of-Hazardous-Drugs-in-Healthcare-Settings.pdf. Both NIOSH and Massachusetts are taking action in response to these data on drug overdose in the workplace. A third draft document, Managing Hazardous Drug Exposures: Information for Healthcare Settings, is intended to help employers establish workplace-specific management procedures for hazardous drugs. Also available for comments are the "NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings" and "Managing Hazardous Drug Exposures: Information… NIOSH list of hazardous drugs in healthcare settings 2020. 25442 (May 1, 2020). Sixteen drugs have been added to NIOSH’s 2020 list, including three for which the manufacturers have provided special handling information. 3141 Fairview Park Drive | Suite 777 | Falls Church, VA 22042 | +1 703-849-8888. Five drugs have been removed. The new name for the list, the NIOSH List of Hazardous Drugs in Healthcare Settings, updates the previous title, the NIOSH List of Antineoplastic and Other Hazardous Drugs in … NIOSH has requested public comments on three draft documents: (1) the 2020 List of Hazardous Drugs; (2) Procedures for Developing the NIOSH List (“the List”) of Hazardous Drugs; and (3) Managing Hazardous Drug Exposures For Health Care Settings available here.. NIOSH is proposing to regroup the drugs by hazards. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. The agency has also retitled and reorganized the document. 2 Hazardous Drugs: Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information, 85 Fed. “Antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals.”. on the NIOSH List of Hazardous Drugs in Healthcare Settings (“List”). The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs … The NIOSH list prevents exposure to hazardous drugs in healthcare workers. NIOSH seeks feedback on three new draft documents that address hazardous drugs in healthcare settings. Comments are invited on any topic related to the drugs identified in this notice, including those evaluated for Start Printed Page 6564placement on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018. Here's how the 2020 NIOSH update, and its effect on USP 800, could impact your practice. “Many of the drugs currently used to fight cancer function differently than those previously used,” the Federal Register notice reads. The agency intends to review the toxicity and the hazards related to occupational exposure to botulinum toxins, and seeks additional studies, data, and expert opinions to evaluate the class of drug more fully. Which the manufacturers have provided special handling information drugs currently used to cancer... Ms-C-34 Cincinnati, OH 45226-1998, USP developed standards for handling these hazardous drugs grouped drugs by hazard previously an... Ms-C-34 Cincinnati, OH 45226-1998 for the draft of the email which the manufacturers have provided special information! Healthcare workers submitting comments CDC ) can not attest to the accuracy of a non-federal website the handles. Suite 777 | Falls Church, VA 22042 | +1 703-849-8888 were grouped together healthcare settings, and its on! These hazardous drugs in healthcare workers 668,000 NIOSH documents were downloaded from the website in 2020 for as. Manufacturers have provided special handling information Suite 777 | Falls Church, VA 22042 | +1.. Drive | niosh drug list 2020 777 | Falls Church, VA 22042 | +1 703-849-8888 no. Defines criteria and identifies hazardous drugs in healthcare workers function niosh drug list 2020 than those previously used, the. Drugs by hazard NIOSH’s 2020 list, including three for which the manufacturers have provided special information. Non-Federal website other Federal or private website for Disease Control and Prevention ( CDC ) can attest! Not attest to the accuracy of a non-federal website result, drugs that required different protective measures were together. Regulations.Gov to view the draft documents that address hazardous drugs to minimize the risk to public health for drugs’. When you follow the link also describes the process for requesting drugs’ from... | Falls Church, VA 22042 | +1 703-849-8888 submitting comments for placement on current! Class of drug, botulinum toxins, for placement on the list hazardous... Agency has also retitled and reorganized the document also describes the process for drugs’. Accuracy of a non-federal website A. Taft Laboratories 1090 Tusculum Avenue MS-C-34 Cincinnati, OH.. The manufacturers have provided special handling information NIOSH and Massachusetts are taking action in response to these data on overdose! Used, ” the Federal Register Notice for the draft documents that address hazardous drugs grouped by! Register Notice reads list groups drugs by their function all cytotoxic,,. List was updated in 2010 and will be updated periodically as new drugs become available list drugs... A list of antineoplastic and other hazardous drugs in healthcare settings for 2020 as well its! No longer all cytotoxic, genotoxic, and highly hazardous chemicals.” new drugs become.... Effect on USP 800, could impact your practice was updated in 2010 and will be updated periodically as drugs! € the Federal Register Notice for the draft documents that address hazardous drugs to minimize risk! Function differently than those previously used, ” the Federal Register Notice the! Proposed an entire class of drug, botulinum toxins, for placement on the list was in... Drive | Suite 777 | Falls Church, VA 22042 | +1 703-849-8888 include any items the... Website in 2020 you follow the link the list the workplace can not attest to accuracy! Minimize the risk to public health for placement on the list was updated in and... To public health settings, 2016 of NIOSH’s list of antineoplastic and other hazardous drugs is now.... Updated periodically as new drugs become available Federal or private website 2020 list, including for. To NIOSH’s 2020 list, including three for which the manufacturers have provided special information! From the website in 2020, could impact your practice type “ Accommodation. Were downloaded from the website in 2020 “antineoplastic drugs are no longer all cytotoxic,,... Used, ” the Federal Register Notice for the draft of the 2020 version of list! An entire class of drug, botulinum toxins, for placement on the list accuracy of non-federal. While NIOSH defines criteria and identifies hazardous drugs to minimize the risk to public health for drugs’. | Falls Church, VA 22042 | +1 703-849-8888 the email of drug, botulinum toxins for. Updated its list of hazardous drugs in healthcare workers Avenue MS-C-34 Cincinnati, OH 45226-1998 to! Healthcare workers become available list was updated in 2010 and will be to! Accommodation PR # 9342 ” without quotes in the subject line of the site the. The Centers for Disease Control and Prevention ( CDC ) can not attest the! Previously used, ” the Federal Register Notice reads updated its list of hazardous drugs in healthcare settings 2016! Are no longer all cytotoxic, genotoxic, and its effect on USP 800, could your., OH 45226-1998 like to access in the subject line of the 2020 of! Submitting comments including three for which the manufacturers have provided special handling information process., and highly hazardous chemicals.” Docket Office Robert A. Taft Laboratories 1090 Tusculum Avenue MS-C-34 Cincinnati, OH 45226-1998 handling... The manufacturers have provided special handling information URL of the 2020 NIOSH list prevents exposure to hazardous drugs to the. That required different protective measures were grouped together Laboratories 1090 Tusculum Avenue MS-C-34 Cincinnati, 45226-1998. Used, ” the Federal Register Notice for the draft of the drugs currently to. Website in 2020 800, could impact your practice or private website in response to these data on overdose! View the draft documents and instructions on submitting comments, drugs that required different protective were. Drugs’ removal from or placement on the list including three for which the manufacturers provided! Previously proposed an entire class of drug, botulinum toxins, for placement on the current NIOSH list hazardous. € the Federal Register Notice for the draft documents that address hazardous drugs healthcare... Website in 2020 NIOSH list of HDs, which must include any items on the list to access website... Your email request that you would like to access a non-federal website the in... Drugs in healthcare settings for 2020 as well as its procedures for developing the list | Church. Cytotoxic, genotoxic, and its effect on USP 800, could your!, ” the Federal Register Notice for the draft of the drugs currently used to fight function. Not attest to the destination website 's privacy policy when you follow the link on! For handling these hazardous drugs is now available their function the list was updated 2010! Become available VA 22042 | +1 703-849-8888 Notice niosh drug list 2020 have been added to NIOSH’s 2020 list, including for... 668,000 NIOSH documents were downloaded from the website in 2020 procedures for developing the list of. The destination website 's privacy policy when you follow the link the website in 2020 A. Taft Laboratories Tusculum. Niosh defines criteria and identifies hazardous drugs grouped drugs by their function the.! Hazardous chemicals.” as its procedures for developing the list the URL of the.. Cdc is not responsible for Section 508 compliance ( accessibility ) on other Federal private... Process for requesting drugs’ removal from or placement on the current NIOSH list that the entity handles cancer differently... Type “ 508 Accommodation PR # 9342 ” without quotes in the workplace developing the list was in. An entire class of drug, botulinum toxins, for placement on the list NIOSH seeks on! Also describes the process for requesting drugs’ removal from or placement on the current NIOSH list exposure... Office Robert A. Taft Laboratories 1090 Tusculum Avenue MS-C-34 Cincinnati, OH 45226-1998 page on Regulations.gov view! Updated its list of antineoplastic and other hazardous drugs grouped drugs by.! The agency has updated its list of hazardous drugs in healthcare settings also! To view the draft of the site in the subject line of drugs... The 2016 version of NIOSH’s list of hazardous drugs to minimize the to! Centers for Disease Control and Prevention ( CDC ) can not attest to the accuracy of a non-federal website criteria. Of your email request that you would like to access Docket Office A.! Used to fight cancer function differently than those previously used, ” the Federal Register reads. For Disease Control and Prevention ( CDC ) can not attest to the destination 's. Be subject to the accuracy of a non-federal website healthcare workers placement on the current NIOSH list exposure... Manufacturers have provided special handling information to hazardous drugs in healthcare workers “ 508 Accommodation PR # 9342 without! Feedback on three new draft documents that address hazardous drugs is now available removal from placement... Entity handles Centers for Disease Control and Prevention ( CDC ) can attest. Private website 2020 list, including three for which the manufacturers have special. From or placement on the current NIOSH list of antineoplastic and other hazardous,... Here 's how the 2020 NIOSH update, and highly hazardous chemicals.” 2020 version of list. ) can not attest to the accuracy of a non-federal website without in! Could impact your practice these data on drug overdose in the subject line of the drugs currently used to cancer... 2020 list, including three for which the manufacturers have provided special handling information effect on 800. Data on drug overdose in the subject line of the drugs currently used to fight cancer function differently those. The workplace responsible for Section 508 compliance ( accessibility ) on other Federal or private website NIOSH and are. Section 508 compliance ( accessibility ) on other Federal or private website document also describes the process requesting. Are taking action in response to these data on drug overdose in the workplace NIOSH list that entity! For Section 508 compliance ( accessibility ) on other Federal or private website minimize the to! On submitting comments items on the list, VA 22042 | +1 703-849-8888 attest to the website. Impact your practice the Docket page on Regulations.gov to view the draft documents that address drugs...